Prehospital HBOC-201 after traumatic brain injury and hemorrhagic shock in swine

Journal of Trauma - Injury, Infection and Critical Care

Volumn 61, Issue 1, 2006, Pages 46-56

  Patel, Mayur B ^a   Feinstein, Ara J ^a   Saenz, Alvaro D ^a   Majetschak, Matthias ^a   Proctor, Kenneth G ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Blood substitute; Brain injury; HBOC; Hemoglobin based oxygen carrier; Swine

Indexed keywords

CYTOKINE; LACTIC ACID; MANNITOL; PHENYLEPHRINE; POLYMERIZED HEMOGLOBIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; BLOOD CLOTTING; BRAIN; BRAIN PERFUSION; BRAIN TISSUE; CONTROLLED STUDY; CRYSTALLOID; EMERGENCY CARE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRIN FORMATION; HEART OUTPUT; HEART RATE; HEMORRHAGIC SHOCK; HISTOLOGY; MALE; MEAN ARTERIAL PRESSURE; NEUROPATHOLOGY; NONHUMAN; OXYGEN TENSION; OXYGENATION; PRIORITY JOURNAL; RESUSCITATION; SWINE; THROMBOELASTOGRAPHY; TRAUMATIC BRAIN INJURY;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD COAGULATION; BLOOD SUBSTITUTES; BRAIN; BRAIN INJURIES; CEREBROVASCULAR CIRCULATION; CYTOKINES; DRUG TOXICITY; FEMALE; FLUID THERAPY; HEMODYNAMIC PROCESSES; HEMOGLOBINS; MALE; SHOCK, HEMORRHAGIC; SWINE;

EID: 33746218381     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/01.ta.0000219730.71206.3a     Document Type: Article

References (49)

1. Moore EE, Johnson JL, Cheng AM, Masuno T, Banerjee A. Insights from studies of blood substitutes in trauma. Shock. 2005;24:197-205.
2. Greenburg AG, Kim HW. Hemoglobin-based oxygen carriers. Crit Care. 2004;8:S61-S64.
3. Wahr JA. Clinical potential of blood substitutes or oxygen therapeutics during cardiac surgery. Anesthesiol Clin North America. 2003;21:553-568.
4. Levy JH. The use of haemoglobin glutamer-250 (HBOC-201) as an oxygen bridge in patients with acute anaemia associated with surgical blood loss. Expert Opin Biol Ther. 2003;3:509-517.
5. Moore EE. Blood substitutes: the future is now. J Am Coll Surg. 2003;196:1-17.
6. Reid TJ. Hb-based oxygen carriers: are we there yet? Transfusion. 2003;43:280-287.
7. U.S. Department of Health and Human Services, Food and Drug Administration Center for Biologies Evaluation and Research. Criteria for safety and efficacy evaluation of oxygen therapeutics as red blood cell substitutes [FDA Website]. Updated November 1, 2005. Available at: http://www.fda.gov/cber/ gdlns/oxytherbld.htm. Accessed December 03, 2005.
8. Brain Trauma Foundation, American Association of Neurological Surgeons, Joint Section on Neurotrauma and Critical Care. Management and prognosis of severe traumatic brain injury [Brain Trauma Foundation Website]. 2000. Available at: http://www2.braintrauma.org/guidelines/downloads/ btf_rguidelines_rmanagement.pdf. Accessed December 03, 2005.
9. Malhotra AK, Schweitzer JB, Fox JL, Fabian TC, Proctor KG. Cerebral perfusion pressure elevation with oxygen carrying pressor after traumatic brain injury and hypotension in swine. J Trauma. 2004;56:1049-1057.
10. Gibson JB, Maxwell RA, Schweitzer JB, Fabian TC, Proctor KG. Resuscitation from severe hemorrhagic shock after traumatic brain injury using saline, shed blood or a blood substitute. Shock. 2002;17:234-244.
11. King DR, Cohn SM, Proctor KG. Resuscitation with a hemoglobin-based oxygen carrier after traumatic brain injury. J Trauma. 2005;59:553-562.
12. Torres Filho IP, Spiess BD, Barbee RW, Ward KR, Oldenhof J, Pittman RN. Systemic responses to hemodilution after transfusion with stored blood and with a hemoglobin-based oxygen carrier. Anesth Analg. 2005;100:912-920.
13. Hare GM, Hum KM, Kim SY, Barr A, Baker AJ, Mazer CD. Increased cerebral tissue oxygen tension after extensive hemodilution with a hemoglobin-based oxygen carrier. Anesth Analg. 2004;99:528-535.
14. Manley GT, Hemphill JC, Morabito D, et al. Small-volume resuscitation with the hemoglobin substitute HBOC-201: effect on brain tissue oxygenation. Adv Exp Med Biol. 2003;530:311-317.
15. Lee SK, Morabito D, Hemphill JC, et al. Small-volume resuscitation with HBOC-201: effects on cardiovascular parameters and brain tissue oxygen tension in an out-of-hospital model of hemorrhage in swine. Acad Emerg Med. 2002;9:969-976.
16. Crookes BA, Cohn SM, Burton EA, Nelson J, Proctor KG. Non-invasive muscle oxygenation to guide fluid resuscitation after traumatic shock. Surgery. 2004;135:662-670.
17. Malhotra AK, Schweitzer JB, Fox JL, Fabian TC, Proctor KG. Cerebral perfusion pressure directed therapy following traumatic brain injury and hypotension in swine. J Neurotrauma. 2003;20:827-839.
18. King DR, Cohn SM, Proctor KG. Changes in intracranial pressure, coagulation and neurologic outcome after resuscitation from experimental traumatic brain injury with Hetastarch. Surgery. 2004;136:355-363.
19. Feinstein AJ, Patel MB, Sanui M, Cohn SM, Majetschak M, Proctor KG. Resuscitation with pressors after traumatic brain injury. J Am Coll Surg. 2005;201:536-545.
20. Sahuquillo J, Poca MA, Ausina A, Baguena M, Gracia RM, Rubio E. Arterio-jugular differences of oxygen (AVDO2) for bedside assessment of CO2-reactivity and autoregulation in the acute phase of severe head injury. Acta Neurochir (Wien). 1996;138:435-444.
21. Katz LM, Manning JE, McCurdy S, et al. Carolina Resuscitation Research Group. HBOC-201 improves survival in a swine model of hemorrhagic shock and liver injury. Resuscitation. 2002;54:77-87.
22. Loke KE, Forfia PR, Recchia FA, et al. Bovine polymerized hemoglobin increases cardiac oxygen consumption and alters myocardial substrate metabolism in conscious dogs: role of nitric oxide. J Cardiovasc Pharmacol. 2000;35:84-92.
23. Fitzpatrick CM, Savage SA, Kerby JD, Clouse WD, Kashyap VS. Resuscitation with a blood substitute causes vasoconstriction without nitric oxide scavenging in a model of arterial hemorrhage. J Am Coll Surg. 2004;199:693-701.
24. Saxena R, Wijnhoud AD, Carton H, et al. Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke. 1999;30:993-996.
25. Cole DJ, Reynolds LW, Nary JC, Drummond JC, Patel PM, Jacobsen WK. Subarachnoid hemorrhage in rats: effect of singular or sustained hemodilution with alpha-alpha diaspirin crosslinked hemoglobin on cerebral hypoperfusion. Crit Care Med. 1999;27:972-977.
26. Cole DJ, McKay LD, Drummond JC, Patel PM, Cross LM. Subarachnoid molecular hemoglobin after subarachnoid hemorrhage in rats: effect on the area of hypoperfusion. J Neurosurg Anesthesiol. 1998;10:153-159.
27. Piper IR, Garrioch MA, Souter MJ, Andrews PJ, Thomson D. Effects of diaspirin cross-linked haemoglobin on post-traumatic cerebral perfusion pressure and blood flow in a rodent model of diffuse brain injury. Br J Anaesth. 1998;80:639-643.
28. Ortegon DP, Dixon PS, Crow KK, Mueller DL, Kerby JD. The effect of the bovine hemoglobin oxygen therapeutic HBOC-201 on human neutrophil activation in vitro. J Trauma. 2003;55:755-760.
29. Voelckel WG, Raedler C, Wenzel V, et al. Arginine vasopressin, but not epinephrine, improves survival in uncontrolled hemorrhagic shock after liver trauma in pigs. Crit Care Med. 2003;31:1160-1165.
30. Raedler C, Voelckel WG, Wenzel V, et al. Treatment of uncontrolled hemorrhagic shock after liver trauma: fatal effects of fluid resuscitation versus improved outcome after vasopressin. Anesth Analg. 2004;98:1759-1766.
31. Sanui M, King DR, Feinstein AJ, Varon AJ, Cohn SM, Proctor KG. Effects of Arginine Vasopressin During Resuscitation from Hemorrhagic Hypotension after Traumatic Brain Injury. Crit Care Med. 2006;34:433-438.
32. Maxwell RA, Gibson JB, Fabian TC, Proctor KG. Resuscitation of severe chest trauma with four different hemoglobin-based oxygen carrying (HBOC) solutions. J Trauma. 2000;49:200-211.
33. Sampson JB, Davis MR, Mueller DL, Kashyap VS, Jenkins DH, Kerby JD. A comparison of the hemoglobin-based oxygen carrier HBOC-201 to other low-volume resuscitation fluids in a model of controlled hemorrhagic shock. J Trauma. 2003;55:747-754.
34. Carrillo EH, Gordon LE, Richardson JD, Polk HC Jr. Free hemoglobin enhances tumor necrosis factor-alpha production in isolated human monocytes. J Trauma. 2002;52:449-452.
35. McFaul SJ, Bowman PD, Villa VM, Gutierrez-Ibanez MJ, Johnson M, Smith D. Hemoglobin stimulates mononuclear leukocytes to release interleukin-8 and tumor necrosis factor alpha. Blood. 1994;84:3175-3181.
36. Hamilton RG, Kelly N, Gawryl MS, Rentko VT. Absence of immunopathology associated with repeated IV administration of bovine Hb-based oxygen carrier in dogs. Transfusion. 2001;41:219-225.
37. Dong F, Hall CH, Golech SA, et al. Immune effects of resuscitation with HBOC-201, a hemoglobin-based oxygen carrier, in swine with moderately severe hemorrhagic shock from controlled hemorrhage. Shock. 2006;25:50-55.
38. Johnson JL, Moore EE, Offner PJ, et al. Resuscitation with a blood substitute abrogates pathologic postinjury neutrophil cytotoxic function. J Trauma. 2001;50:449-455.
39. Sheppard FR, Moore EE, Johnson JL, Cheng AM, McLaughlin N, Silliman CC. Transfusion-induced leukocyte IL-8 gene expression is avoided by the use of human polymerized hemoglobin. J Trauma. 2004;57:720-724.
40. Johnson JL, Moore EE, Gonzalez RJ, Fedel N, Partrick DA, Silliman CC. Alteration of the postinjury hyperinflammatory response by means of resuscitation with a red cell substitute. J Trauma. 2003;54:133-139.
41. Schmidt OI, Heyde CE, Ertel W, Stahel PF. Closed head injury: an inflammatory disease? Brain Res Brain Res Rev. 2005;48:388-399.
42. Csuka E, Morganti-Kossmann MC, Lenzlinger PM, Joller H, Trentz O, Kossmann T. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function. J Neuroimmunol. 1999;101:211-221.
43. Ross SA, Halliday MI, Campbell GC, Byrnes DP, Rowlands BJ. The presence of tumour necrosis factor in CSF and plasma after severe head injury. Br J Neurosurg. 1994;8:419-425.
44. Shiozaki T, Hayakata T, Tasaki O, et al. Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury. Shock. 2005;23:406-410.
45. Moreira PL, Lansden CC, Clark TL, Gawryl MS. Effect of Hemopure on prothrombin time and activated partial thromboplastin time on seven coagulation analyzers. Clin Chem. 1997;43:1792.
46. Jahr JS, Lurie F, Gosselin R, et al. Effects of hemoglobin glutamer-250 (bovine) (HBOC-201, Hemopure) on coagulation testing. Am J Ther. 2002;9:431-436.
47. Marret E, Bonnin P, Mazoyer E, et al. The effects of a polymerized bovine-derived hemoglobin solution in a rabbit model of arterial thrombosis and bleeding. Anesth Analg. 2004;98:604-610.
48. James MF, Potgieter HE, Ellis P. The effect of hemopure on coagulation in clinically relevant concentrations. Anesth Analg. 2004;99:1593-1597.
49. Arnaud F, Hammett M, Asher L, et al. Effects of bovine polymerized hemoglobin on coagulation in controlled hemorrhagic shock in swine. Shock. 2005;24:145-152.